BRAF and neoplasm: Although some studies have explored CRT sensitivity in BRAF-mutant CRCs [5, 14, 19], their conclusions are inconsistent, with small sample sizes and lack of validation, highlighting the need for further investigation into the radiobiological characteristics of this kind of tumor.